Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 19, Avenue Du Professeur Cadiot, Maisons Alfort,île-De-France 94700,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cellvax-pharma.com
- Keywords
- Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, Subcutaneous & Orthotopic cancer models, Syngeneic tumor models, PK/Bio-distribution, In vivo imaging, Histology, Toxicology studies, Rodents & non-rodents.
- HQ
- MAISONS ALFORT, Île-de-France
Cellvax Questions
Cellvax's website is cellvax-pharma.com
Cellvax's LinkedIn profile is https://fr.linkedin.com/company/cellvax-pharma
Cellvax has
7 employees.
View email and phone details for 7
employees at Cellvax.
Cellvax's industry is
Biotechnology Research
Cellvax's top competitors are
Nanobiotix,
Innoverda,
Brainstorm Cell Therapeutics,
Clarity Pharmaceuticals,
Theragent Inc,
Cellvax Therapeutics, Inc.,
Spectronrx,
Valotec,
Alaya.bio,
Transgene.
Cellvax's categories are Biotechnology Research
Cellvax's founding year is 2001
